Genetic polymorphisms of histone methyltransferase SETD2 predicts prognosis and chemotherapy response in Chinese acute myeloid leukemia patients
Abstract Background SETD2, the single mediator of trimethylation of histone 3 at position lysine 36, has been reported associated with initiation progression and chemotherapy resistance in acute myeloid leukemia (AML). Whether polymorphisms of SETD2 affect prognosis and chemotherapy response of AML...
Main Authors: | Suwei Wang, Xiaoqing Yuan, Yazhen Liu, Kewei Zhu, Peng Chen, Han Yan, Daoyu Zhang, Xi Li, Hui Zeng, Xielan Zhao, Xiaoping Chen, Gan Zhou, Shan Cao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-019-1848-9 |
Similar Items
-
Lysine methyltransferase SETD6 modifies histones on a glycine-lysine motif
by: Olivier Binda
Published: (2020-02-01) -
Downregulation of trimethyl transferase SETD2 promotes migration and proliferation of colorectal cancer cell
by: CUI Ang, DING Jiazeng, CHEN Haizhen, SHEN Xiaohui, LI Chaofei, LIU Guoliang
Published: (2020-03-01) -
SETD2 loss in renal epithelial cells drives epithelial‐to‐mesenchymal transition in a TGF‐β‐independent manner
by: Tianchu Wang, et al.
Published: (2024-01-01) -
Histone Methyltransferase SETD2 Is Required for Porcine Early Embryonic Development
by: Weini Shao, et al.
Published: (2022-08-01) -
Discovery of a Non-Nucleoside SETD2 Methyltransferase Inhibitor against Acute Myeloid Leukemia
by: Dávid Bajusz, et al.
Published: (2021-09-01)